About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Chi3l1tm1Eli
targeted mutation 1, Jack A Elias
MGI:3846187
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Chi3l1tm1Eli/Chi3l1tm1Eli B6.Cg-Chi3l1tm1Eli MGI:3846223
cx2
Chi3l1tm1Eli/Chi3l1tm1Eli
Tg(Scgb1a1-rtTA,-tTS,tetO-CHI3L1)1Eli/0
involves: 129 * C57BL/6 MGI:3846227
cx3
Chi3l1tm1Eli/Chi3l1tm1Eli
Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0
involves: C57BL/6 * CBA MGI:3846225


Genotype
MGI:3846223
hm1
Allelic
Composition
Chi3l1tm1Eli/Chi3l1tm1Eli
Genetic
Background
B6.Cg-Chi3l1tm1Eli
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Chi3l1tm1Eli mutation (0 available); any Chi3l1 mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• T cells, macrophages and eosinophils have increased rates of apoptosis in the lungs of mice sensitized and then challenged with OVA compared to controls
• there is increased number of apoptotic CD4+ T cells in the lungs of mice sensitized and then challenged with OVA compared to controls
• percentage of apoptotic cells is also increased in vitro when T cells are cultured with TNF or Fas-ligand
• splenocyte proliferation in response to OVA sensitization and challenge is reduced compared to controls

immune system
• there is increased number of apoptotic CD4+ T cells in the lungs of mice sensitized and then challenged with OVA compared to controls
• percentage of apoptotic cells is also increased in vitro when T cells are cultured with TNF or Fas-ligand
• splenocyte proliferation in response to OVA sensitization and challenge is reduced compared to controls
• numbers of Th2 CD4+ cells are reduced by half in the lung after OVA-plus-alum sensitization and challenge compared to controls
• alternatively activated macrophage numbers are reduced by half compared to controls in mice that received OVA-plus-alum sensitization and challenge
• eosinophil recruitment to the lung is impaired after OVA-plus-alum sensitization and challenge compared to controls
• neutrophil recruitment to the lung is impaired after OVA-plus-alum sensitization and challenge compared to controls
• antigen specific IgE levels are significantly less than controls after OVA sensitization and challenge
• numbers of Th2 CD4+ cells are reduced by half in the lung after OVA-plus-alum sensitization and challenge compared to controls
• dendritic cell recruitment to the lungs is impaired after OVA sensitization and challenge compared to controls
• in addition, expression of the activation markers CD40 and CD86 on these cells are also decreased compared to controls
• plasmacytoid dendritic cell recruitment to the lung is impaired after OVA sensitization and challenge compared to controls
• in addition, expression of the activation markers CD40 and CD86 on these cells are decreased compared to controls
• IL-13 secretion is reduced in the lung by more than 80% after OVA-plus-alum sensitization and challenge compared to controls
• IL-4 secretion is greatly reduced in the lung after OVA-plus-alum sensitization and challenge compared to controls

hematopoietic system
• there is increased number of apoptotic CD4+ T cells in the lungs of mice sensitized and then challenged with OVA compared to controls
• percentage of apoptotic cells is also increased in vitro when T cells are cultured with TNF or Fas-ligand
• splenocyte proliferation in response to OVA sensitization and challenge is reduced compared to controls
• numbers of Th2 CD4+ cells are reduced by half in the lung after OVA-plus-alum sensitization and challenge compared to controls
• alternatively activated macrophage numbers are reduced by half compared to controls in mice that received OVA-plus-alum sensitization and challenge
• eosinophil recruitment to the lung is impaired after OVA-plus-alum sensitization and challenge compared to controls
• neutrophil recruitment to the lung is impaired after OVA-plus-alum sensitization and challenge compared to controls
• antigen specific IgE levels are significantly less than controls after OVA sensitization and challenge
• numbers of Th2 CD4+ cells are reduced by half in the lung after OVA-plus-alum sensitization and challenge compared to controls




Genotype
MGI:3846227
cx2
Allelic
Composition
Chi3l1tm1Eli/Chi3l1tm1Eli
Tg(Scgb1a1-rtTA,-tTS,tetO-CHI3L1)1Eli/0
Genetic
Background
involves: 129 * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Chi3l1tm1Eli mutation (0 available); any Chi3l1 mutation (29 available)
Tg(Scgb1a1-rtTA,-tTS,tetO-CHI3L1)1Eli mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• Th2 responses to OVA sensitization and challenge to the lungs is similar to wild-type controls but is less than in mice homozygous for just the Chi3l1tm1Eli allele




Genotype
MGI:3846225
cx3
Allelic
Composition
Chi3l1tm1Eli/Chi3l1tm1Eli
Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0
Genetic
Background
involves: C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Chi3l1tm1Eli mutation (0 available); any Chi3l1 mutation (29 available)
Tg(Scgb1a1-rtTA,tetO-Il13)1Eli mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• in mice administered doxycycline, Th2 cell numbers found in the lungs of mice sensitized and challenged with OVA are greater than in wild-type controls but less than in mice carrying just the transgene
• in mice administered doxycycline, Th2 responses to OVA sensitization and challenge to the lungs is greater than wild-type controls but less than in mice carrying just the transgene

hematopoietic system
• in mice administered doxycycline, Th2 cell numbers found in the lungs of mice sensitized and challenged with OVA are greater than in wild-type controls but less than in mice carrying just the transgene
• in mice administered doxycycline, Th2 responses to OVA sensitization and challenge to the lungs is greater than wild-type controls but less than in mice carrying just the transgene





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory